<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0033">
 <label>33</label>
 <element-citation publication-type="journal" id="sbref0029">
  <person-group person-group-type="author">
   <name>
    <surname>Matthay</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Calfee</surname>
    <given-names>C.S.</given-names>
   </name>
   <name>
    <surname>Zhuo</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Thompson</surname>
    <given-names>B.T.</given-names>
   </name>
   <name>
    <surname>Wilson</surname>
    <given-names>J.G.</given-names>
   </name>
   <name>
    <surname>Levitt</surname>
    <given-names>J.E.</given-names>
   </name>
  </person-group>
  <article-title>Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial</article-title>
  <source>Lancet Respir Med</source>
  <volume>7</volume>
  <year>2019</year>
  <fpage>154</fpage>
  <lpage>162</lpage>
  <pub-id pub-id-type="pmid">30455077</pub-id>
 </element-citation>
</ref>
